Hotchkis & Wiley Capital Management LLC Siga Technologies Inc Transaction History

Hotchkis & Wiley Capital Management LLC

$30.4 Billion
Q3 2025

A detailed history of Hotchkis & Wiley Capital Management LLC transactions in Siga Technologies Inc stock. As of the latest transaction made, Hotchkis & Wiley Capital Management LLC holds 827,587 shares of SIGA stock, worth $4.97 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

827,587

Previous 2,067,760 59.98%

Holding current value

$4.97 Million

Previous $13.5 Million 43.83%

% of portfolio

0.02%

Previous 0.05%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$6.46 - $9.48 $8.01 Million - $11.8 Million	-1,240,173 Reduced 59.98%	827,587 $7.57 Million
Q2 2025 Aug 13, 2025	SELL	$5.22 - $6.56 $5.69 Million - $7.15 Million	-1,090,560 Reduced 34.53%	2,067,760 $13.5 Million
Q1 2025 May 14, 2025	BUY	$5.39 - $6.47 $5.89 Million - $7.07 Million	1,093,080 Added 52.93%	3,158,320 $17.3 Million
Q4 2024 Feb 14, 2025	BUY	$5.73 - $7.72 $96,264 - $129,696	16,800 Added 0.82%	2,065,240 $12.4 Million
Q3 2024 Nov 14, 2024	BUY	$6.74 - $11.97 $8.34 Million - $14.8 Million	1,237,620 Added 152.64%	2,048,440 $13.8 Million

Q2 2024 Aug 14, 2024	SELL	$6.32 - $10.46 $1.77 Million - $2.93 Million	-280,340 Reduced 25.69%	810,820 $6.15 Million
Q1 2024 May 14, 2024	BUY	$4.51 - $8.92 $298,562 - $590,504	66,200 Added 6.46%	1,091,160 $9.34 Million
Q4 2023 Feb 14, 2024	BUY	$4.82 - $6.25 $2.87 Million - $3.72 Million	595,856 Added 138.86%	1,024,960 $5.74 Million
Q3 2023 Nov 13, 2023	BUY	$4.32 - $5.77 $1.85 Million - $2.48 Million	429,104 New	429,104 $2.25 Million

Others Institutions Holding SIGA

# of Institutions

214

Shares Held

35.1M

Call Options Held

74.6K

Put Options Held

22.8K

View Full List

About SIGA TECHNOLOGIES INC

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

More about SIGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.

Account

Hotchkis & Wiley Capital Management LLC Siga Technologies Inc Transaction History